Gustavo J Borjas

6PUBLICATIONS
49CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 09, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

Roger Li, Nancy Y Villa, Xiaoqing Yu

|Mar 18, 2024
LDL-Binding IL-10 Reduces Vascular Inflammation in Atherosclerotic Mice.

Lisa R Volpatti, Salvador Norton de Matos, Gustavo Borjas

|Aug 02, 2023
Sézary syndrome originates from heavily mutated hematopoietic progenitors.

Carly M Harro, Kimberly B Sprenger, Ricardo A Chaurio

|Jul 28, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder.

Roger Li, Wade J Sexton, Jasreman Dhillon

Pageof 1